Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Income from Continuous Operations 2010-2025 | BMY

Bristol Myers Squibb annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • Bristol Myers Squibb income from continuous operations for the quarter ending June 30, 2025 was $1.313B, a 22.03% decline year-over-year.
  • Bristol Myers Squibb income from continuous operations for the twelve months ending June 30, 2025 was $5.066B, a 177.6% decline year-over-year.
  • Bristol Myers Squibb annual income from continuous operations for 2024 was $-8.933B, a 211.11% decline from 2023.
  • Bristol Myers Squibb annual income from continuous operations for 2023 was $8.04B, a 26.71% increase from 2022.
  • Bristol Myers Squibb annual income from continuous operations for 2022 was $6.345B, a 9.54% decline from 2021.
  
Bristol Myers Squibb Annual Income from Continuous Operations
(Millions of US $)
2024 $-8,933
2023 $8,040
2022 $6,345
2021 $7,014
2020 $-8,995
2019 $3,460
2018 $4,947
2017 $975
2016 $4,507
2015 $1,631
2014 $2,029
2013 $2,580
2012 $2,501
2011 $5,260
2010 $4,513
2009 $4,420
Bristol Myers Squibb Quarterly Income from Continuous Operations
(Millions of US $)
2025-06-30 $1,313
2025-03-31 $2,462
2024-12-31 $76
2024-09-30 $1,215
2024-06-30 $1,684
2024-03-31 $-11,908
2023-12-31 $1,762
2023-09-30 $1,934
2023-06-30 $2,077
2023-03-31 $2,267
2022-12-31 $2,025
2022-09-30 $1,608
2022-06-30 $1,429
2022-03-31 $1,283
2021-12-31 $2,372
2021-09-30 $1,552
2021-06-30 $1,061
2021-03-31 $2,029
2020-12-31 $-10,027
2020-09-30 $1,878
2020-06-30 $-80
2020-03-31 $-766
2019-12-31 $-1,060
2019-09-30 $1,366
2019-06-30 $1,439
2019-03-31 $1,715
2018-12-31 $1,158
2018-09-30 $1,912
2018-06-30 $382
2018-03-31 $1,495
2017-12-31 $-2,329
2017-09-30 $856
2017-06-30 $922
2017-03-31 $1,526
2016-12-31 $898
2016-09-30 $1,215
2016-06-30 $1,188
2016-03-31 $1,206
2015-12-31 $-188
2015-09-30 $730
2015-06-30 $-110
2015-03-31 $1,199
2014-12-31 $27
2014-09-30 $732
2014-06-30 $334
2014-03-31 $936
2013-12-31 $735
2013-09-30 $692
2013-06-30 $530
2013-03-31 $623
2012-12-31 $924
2012-09-30 $-713
2012-06-30 $808
2012-03-31 $1,482
2011-12-31 $1,231
2011-09-30 $1,355
2011-06-30 $1,307
2011-03-31 $1,367
2010-12-31 $842
2010-09-30 $1,302
2010-06-30 $1,268
2010-03-31 $1,101
2009-12-31 $1,132
2009-09-30 $1,199
2009-06-30 $1,169
2009-03-31 $920
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $97.538B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $251.118B 18.32
Amgen (AMGN) United States $158.128B 13.47
Gilead Sciences (GILD) United States $142.407B 14.83
Vertex Pharmaceuticals (VRTX) United States $101.305B 26.12
GSK (GSK) United Kingdom $81.894B 9.52
CSL (CSLLY) Australia $68.196B 0.00
Regeneron Pharmaceuticals (REGN) United States $62.477B 15.20
Alnylam Pharmaceuticals (ALNY) United States $59.560B 0.00
Argenex SE (ARGX) Netherlands $40.392B 71.04
Insmed (INSM) United States $27.876B 0.00
BioNTech SE (BNTX) Germany $26.655B 0.00
Royalty Pharma (RPRX) United States $21.181B 8.27
Biogen (BIIB) United States $20.425B 8.70
Incyte (INCY) United States $16.606B 21.15
Genmab (GNMSF) Denmark $16.145B 14.30
Genmab (GMAB) Denmark $15.814B 14.42
Illumina (ILMN) United States $15.647B 24.47
Ascendis Pharma (ASND) Denmark $11.893B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.248B 15.88
QIAGEN (QGEN) Netherlands $11.057B 21.20
Swedish Orphan Biovitrum (BIOVF) Sweden $10.947B 24.21
Moderna (MRNA) United States $10.552B 0.00
Exelixis (EXEL) United States $10.399B 18.75
Exact Sciences (EXAS) United States $8.987B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.987B 0.00
Bio-Techne Corp (TECH) United States $8.950B 33.00
Halozyme Therapeutics (HALO) United States $8.401B 14.78
Roivant Sciences (ROIV) United Kingdom $8.103B 0.00
Guardant Health (GH) United States $7.657B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.468B 39.84
Anbio Biotechnology (NNNN) Germany $7.174B 0.00
Repligen (RGEN) United States $7.020B 76.56
Revolution Medicines (RVMD) United States $6.918B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.859B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Legend Biotech (LEGN) United States $6.535B 0.00
Avidity Biosciences (RNA) United States $5.963B 0.00
Axsome Therapeutics (AXSM) United States $5.914B 0.00
Abivax SA (ABVX) France $5.838B 0.00
Nuvalent (NUVL) United States $5.486B 0.00
Merus (MRUS) Netherlands $5.105B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.940B 0.00
Alkermes (ALKS) Ireland $4.911B 13.65
TG Therapeutics (TGTX) United States $4.672B 79.58
Cytokinetics (CYTK) United States $4.588B 0.00
Ascentage Pharma Group - (AAPG) China $4.453B 0.00
Krystal Biotech (KRYS) United States $4.355B 30.59
ACADIA Pharmaceuticals (ACAD) United States $4.343B 40.22
Zealand Pharma (ZLDPF) Denmark $4.332B 4.28
ADMA Biologics Inc (ADMA) United States $4.248B 30.69
Telix Pharmaceuticals (TLX) Australia $4.223B 0.00
Vaxcyte (PCVX) United States $4.192B 0.00
PTC Therapeutics (PTCT) United States $4.017B 6.67
Arcellx (ACLX) United States $3.953B 0.00
Akero Therapeutics (AKRO) United States $3.938B 0.00
Zai Lab (ZLAB) United States $3.892B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.593B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.590B 0.00
Protagonist Therapeutics (PTGX) United States $3.576B 82.11
Apellis Pharmaceuticals (APLS) United States $3.532B 0.00
Jyong Biotech (MENS) Taiwan $3.497B 0.00
Metsera (MTSR) United States $3.472B 0.00
Scholar Rock Holding (SRRK) United States $3.412B 0.00
Kymera Therapeutics (KYMR) United States $3.153B 0.00
Ligand Pharmaceuticals (LGND) United States $3.117B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.995B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.949B 0.00
Bavarian Nordic (BVNRY) Denmark $2.942B 14.30
Viking Therapeutics (VKTX) United States $2.924B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.870B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.809B 0.00
Immunovant (IMVT) United States $2.657B 0.00
Alvotech (ALVO) Luxembourg $2.548B 19.20
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.501B 843.75
Tarsus Pharmaceuticals (TARS) United States $2.417B 0.00
Amicus Therapeutics (FOLD) United States $2.346B 0.00
Liquidia Technologies (LQDA) United States $2.311B 0.00
Denali Therapeutics (DNLI) United States $2.265B 0.00
Agios Pharmaceuticals (AGIO) United States $2.254B 0.00
Celcuity (CELC) United States $2.224B 0.00
IDEAYA Biosciences (IDYA) United States $2.202B 0.00
ImmunityBio (IBRX) United States $2.184B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.178B 12.21
Recursion Pharmaceuticals (RXRX) United States $2.145B 0.00
Disc Medicine (IRON) United States $2.098B 0.00
CG Oncology (CGON) United States $2.052B 0.00
Belite Bio (BLTE) United States $2.050B 0.00
Mesoblast (MESO) Australia $2.024B 0.00
Adaptive Biotechnologies (ADPT) United States $1.980B 0.00
Sarepta Therapeutics (SRPT) United States $1.976B 0.00
ANI Pharmaceuticals (ANIP) United States $1.975B 17.71
Arcutis Biotherapeutics (ARQT) United States $1.917B 0.00
Vericel (VCEL) United States $1.869B 308.58
Certara (CERT) United States $1.842B 33.74
Apogee Therapeutics (APGE) United States $1.765B 0.00
Twist Bioscience (TWST) United States $1.726B 0.00
Beam Therapeutics (BEAM) United States $1.683B 0.00
Cidara Therapeutics (CDTX) United States $1.683B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.659B 0.00
Biohaven (BHVN) United States $1.651B 0.00
WAVE Life Sciences (WVE) Singapore $1.615B 0.00
Travere Therapeutics (TVTX) United States $1.597B 0.00
Viridian Therapeutics (VRDN) United States $1.570B 0.00
Edgewise Therapeutics (EWTX) United States $1.564B 0.00
Celldex Therapeutics (CLDX) United States $1.492B 0.00
Janux Therapeutics (JANX) United States $1.460B 0.00
Vera Therapeutics (VERA) United States $1.441B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.399B 0.00
89BIO (ETNB) United States $1.399B 0.00
NovoCure (NVCR) Jersey $1.390B 0.00
Cogent Biosciences (COGT) United States $1.380B 0.00
AbCellera Biologics (ABCL) Canada $1.312B 0.00
Novavax (NVAX) United States $1.273B 3.44
MannKind (MNKD) United States $1.261B 37.36
Precigen (PGEN) United States $1.246B 0.00
GRAIL (GRAL) United States $1.234B 0.00
Dynavax Technologies (DVAX) United States $1.231B 52.50
CureVac (CVAC) Germany $1.220B 5.67
Pharvaris (PHVS) Netherlands $1.209B 0.00
Pacira BioSciences (PCRX) United States $1.161B 12.30
LENZ Therapeutics (LENZ) United States $1.141B 0.00
Zymeworks (ZYME) United States $1.135B 0.00
Structure Therapeutics (GPCR) United States $1.130B 0.00
Intellia Therapeutics (NTLA) United States $1.129B 0.00
Arcus Biosciences (RCUS) United States $1.121B 0.00
MiMedx (MDXG) United States $1.082B 24.37
Sionna Therapeutics (SION) United States $1.077B 0.00
Stoke Therapeutics (STOK) United States $1.072B 23.01
Spyre Therapeutics (SYRE) United States $1.050B 0.00
Praxis Precision Medicines (PRAX) United States $1.027B 0.00
CorMedix Inc (CRMD) United States $1.022B 18.25
Nuvation Bio (NUVB) United States $0.993B 0.00
Mineralys Therapeutics (MLYS) United States $0.987B 0.00
Iovance Biotherapeutics (IOVA) United States $0.973B 0.00
Upstream Bio (UPB) United States $0.950B 0.00
Oric Pharmaceuticals (ORIC) United States $0.946B 0.00
Pharming Group (PHAR) Netherlands $0.939B 0.00
Geron (GERN) United States $0.932B 0.00
Trevi Therapeutics (TRVI) United States $0.919B 0.00
Urogen Pharma (URGN) United States $0.899B 0.00
Immunome (IMNM) United States $0.897B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Pharming Group (PHGUF) Netherlands $0.872B 0.00
UniQure (QURE) Netherlands $0.861B 0.00
NeoGenomics (NEO) United States $0.853B 0.00
Sana Biotechnology (SANA) United States $0.851B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.845B 0.00
Anavex Life Sciences (AVXL) United States $0.819B 0.00
ArriVent BioPharma (AVBP) United States $0.816B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.815B 0.00
Niagen Bioscience (NAGE) United States $0.796B 76.77
Gyre Therapeutics (GYRE) United States $0.788B 163.60
Dianthus Therapeutics (DNTH) United States $0.782B 0.00
BGM Group (BGM) China $0.780B 0.00
Oculis Holding AG (OCS) Switzerland $0.779B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.775B 0.00
Nurix Therapeutics (NRIX) United States $0.775B 0.00
Tango Therapeutics (TNGX) United States $0.768B 0.00
Fortrea Holdings (FTRE) United States $0.757B 13.44
Ginkgo Bioworks Holdings (DNA) United States $0.743B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.738B 0.00
Zenas BioPharma (ZBIO) United States $0.720B 0.00
Immatics (IMTX) Germany $0.692B 0.00
Arbutus Biopharma (ABUS) United States $0.688B 0.00
GH Research (GHRS) Ireland $0.681B 0.00
Kura Oncology (KURA) United States $0.664B 0.00
Bicara Therapeutics (BCAX) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Vir Biotechnology (VIR) United States $0.636B 0.00
Keros Therapeutics (KROS) United States $0.632B 50.19
MeiraGTx Holdings (MGTX) United States $0.630B 0.00
Tyra Biosciences (TYRA) United States $0.624B 0.00
Rezolute (RZLT) United States $0.609B 0.00
Terns Pharmaceuticals (TERN) United States $0.606B 0.00
Castle Biosciences (CSTL) United States $0.605B 59.54
Maze Therapeutics (MAZE) United States $0.592B 0.00
Palvella Therapeutics (PVLA) United States $0.591B 0.00
AnaptysBio (ANAB) United States $0.566B 0.00
Myriad Genetics (MYGN) United States $0.560B 0.00
Verastem (VSTM) United States $0.559B 0.00
Rapport Therapeutics (RAPP) United States $0.539B 0.00
Kodiak Sciences (KOD) United States $0.539B 0.00
Arvinas (ARVN) United States $0.537B 0.00
Septerna (SEPN) United States $0.535B 0.00
Gossamer Bio (GOSS) United States $0.532B 0.00
Cytek Biosciences (CTKB) United States $0.528B 0.00
Opthea (OPT) Australia $0.525B 0.00
ATyr Pharma (ATYR) United States $0.524B 0.00
Alumis (ALMS) United States $0.504B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.503B 0.00
Emergent Biosolutions (EBS) United States $0.492B 4.03
Bicycle Therapeutics (BCYC) United Kingdom $0.492B 0.00
Tectonic Therapeutic (TECX) United States $0.490B 0.00
Cullinan Therapeutics (CGEM) United States $0.484B 0.00
MBX Biosciences (MBX) United States $0.481B 0.00
Prime Medicine (PRME) United States $0.478B 0.00
Prothena (PRTA) Ireland $0.472B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.466B 0.00
Eton Pharmaceuticals (ETON) United States $0.464B 0.00
Solid Biosciences (SLDB) United States $0.462B 0.00
PureTech Health (PRTC) United States $0.459B 0.00
REGENXBIO (RGNX) United States $0.455B 0.00
Erasca (ERAS) United States $0.454B 0.00
ITeos Therapeutics (ITOS) United States $0.450B 0.00
Replimune (REPL) United States $0.443B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.432B 0.00
Inventiva S.A (IVA) France $0.428B 0.00
Compass Therapeutics (CMPX) United States $0.418B 0.00
I-Mab (IMAB) United States $0.416B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.414B 0.00
XOMA Royalty (XOMA) United States $0.413B 0.00
Kamada (KMDA) Israel $0.413B 21.12
Aura Biosciences (AURA) United States $0.407B 0.00
Olema Pharmaceuticals (OLMA) United States $0.395B 0.00
Absci (ABSI) United States $0.393B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.393B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.388B 0.00
Astria Therapeutics (ATXS) United States $0.383B 0.00
Fulcrum Therapeutics (FULC) United States $0.372B 0.00
Abeona Therapeutics (ABEO) United States $0.371B 7.86
Northwest Biotherapeutics (NWBO) United States $0.367B 0.00
Inhibrx Biosciences (INBX) United States $0.362B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.358B 0.00
CytomX Therapeutics (CTMX) United States $0.350B 3.79
Benitec Biopharma (BNTC) United States $0.341B 0.00
Amarin (AMRN) Ireland $0.331B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.329B 0.00
Candel Therapeutics (CADL) United States $0.327B 0.00
DiaMedica Therapeutics (DMAC) United States $0.316B 0.00
Foghorn Therapeutics (FHTX) United States $0.314B 0.00
Bright Minds Biosciences (DRUG) United States $0.310B 0.00
Design Therapeutics (DSGN) United States $0.300B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.298B 13.39
Ocugen (OCGN) United States $0.295B 0.00
Crescent Biopharma (CBIO) United States $0.294B 0.00
Cartesian Therapeutics (RNAC) United States $0.292B 0.00
Atea Pharmaceuticals (AVIR) United States $0.290B 0.00
Neurogene (NGNE) United States $0.285B 0.00
Lifecore Biomedical (LFCR) United States $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.281B 0.00
Contineum Therapeutics (CTNM) United States $0.279B 0.00
Vor Biopharma (VOR) $0.275B 0.00
DBV Technologies S.A (DBVT) France $0.274B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.270B 0.00
Jade Biosciences (JBIO) United States $0.269B 0.00
Puma Biotechnology (PBYI) United States $0.264B 5.36
Allogene Therapeutics (ALLO) United States $0.264B 0.00
Tvardi Therapeutics (TVRD) United States $0.263B 0.00
Neumora Therapeutics (NMRA) United States $0.262B 0.00
Codexis (CDXS) United States $0.260B 0.00
Prima BioMed (IMMP) Australia $0.260B 0.00
ScPharmaceuticals (SCPH) United States $0.259B 0.00
Alector (ALEC) United States $0.255B 0.00
Alpha Teknova (TKNO) United States $0.254B 0.00
Annexon (ANNX) United States $0.254B 0.00
Editas Medicine (EDIT) United States $0.252B 0.00
Humacyte (HUMA) United States $0.245B 0.00
Adherex Technologies (FENC) United States $0.241B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.241B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.238B 0.00
Entrada Therapeutics (TRDA) United States $0.234B 0.00
EnGene Holdings (ENGN) Canada $0.221B 0.00
GENFIT S.A (GNFT) France $0.219B 0.00
Sagimet Biosciences (SGMT) United States $0.218B 0.00
AC Immune (ACIU) Switzerland $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Aardvark Therapeutics (AARD) United States $0.212B 0.00
Innate Pharma S.A (IPHA) France $0.207B 0.00
Cognition Therapeutics (CGTX) United States $0.206B 0.00
SELLAS Life Sciences (SLS) United States $0.201B 0.00
Monopar Therapeutics (MNPR) United States $0.198B 0.00
Ventyx Biosciences (VTYX) United States $0.195B 0.00
Elicio Therapeutics (ELTX) United States $0.193B 0.00
Voyager Therapeutics (VYGR) United States $0.190B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.190B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.189B 0.00
Rapt Therapeutics (RAPT) United States $0.187B 0.00
C4 Therapeutics (CCCC) United States $0.186B 0.00
Tenaya Therapeutics (TNYA) United States $0.184B 0.00
Instil Bio (TIL) United States $0.182B 0.00
Immuneering (IMRX) United States $0.178B 0.00
Sangamo Therapeutics (SGMO) United States $0.177B 0.00
Nuvectis Pharma (NVCT) United States $0.175B 0.00
Actuate Therapeutics (ACTU) United States $0.173B 0.00
Caribou Biosciences (CRBU) United States $0.172B 0.00
Tevogen Bio Holdings (TVGN) United States $0.172B 0.00
Seres Therapeutics (MCRB) United States $0.170B 0.00
Nkarta (NKTX) United States $0.168B 0.00
Kyverna Therapeutics (KYTX) United States $0.167B 0.00
Black Diamond Therapeutics (BDTX) United States $0.166B 12.70
Greenwich LifeSciences (GLSI) United States $0.166B 0.00
BioAge Labs (BIOA) United States $0.165B 0.00
TuHURA Biosciences (HURA) United States $0.163B 0.00
Climb Bio (CLYM) United States $0.161B 0.00
Cellectis S.A (CLLS) France $0.158B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.156B 0.00
Cardiff Oncology (CRDF) United States $0.154B 0.00
MaxCyte (MXCT) United States $0.151B 0.00
Theratechnologies (THTX) Canada $0.150B 0.00
Molecular Partners AG (MOLN) Switzerland $0.148B 0.00
Cabaletta Bio (CABA) United States $0.148B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.144B 0.00
Agenus (AGEN) United States $0.144B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.144B 0.00
BioHarvest Sciences (BHST) Canada $0.143B 0.00
Coherus Oncology (CHRS) United States $0.143B 0.00
Genelux (GNLX) United States $0.143B 0.00
Forte Biosciences (FBRX) United States $0.142B 0.00
Anika Therapeutics (ANIK) United States $0.139B 0.00
Zura Bio (ZURA) United States $0.137B 0.00
Citius Oncology (CTOR) United States $0.137B 0.00
Fate Therapeutics (FATE) United States $0.133B 0.00
Scilex Holding (SCLX) United States $0.131B 0.00
Alpha Cognition (ACOG) Canada $0.131B 0.00
Compugen (CGEN) Israel $0.129B 0.00
Oncobiologics (OTLK) United States $0.119B 0.00
Seer (SEER) United States $0.119B 0.00
Coya Therapeutics (COYA) United States $0.115B 0.00
Equillium (EQ) United States $0.113B 0.00
Adagene (ADAG) China $0.113B 0.00
23andMe Holding (MEHCQ) United States $0.109B 0.00
Biomea Fusion (BMEA) United States $0.109B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.107B 0.00
TScan Therapeutics (TCRX) United States $0.106B 0.00
Alto Neuroscience (ANRO) United States $0.106B 0.00
Spero Therapeutics (SPRO) United States $0.105B 0.00
Inovio Pharmaceuticals (INO) United States $0.104B 0.00
HilleVax (HLVX) United States $0.103B 0.00
Connect Biopharma Holdings (CNTB) United States $0.102B 0.00
Skye Bioscience (SKYE) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.099B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.099B 0.00
XBiotech (XBIT) United States $0.098B 0.00
VistaGen Therapeutics (VTGN) United States $0.097B 0.00
BioStem Technologies (BSEM) $0.097B 5.09
Prenetics Global (PRE) Hong Kong, SAR China $0.094B 0.00
Immunic (IMUX) United States $0.094B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.093B 0.00
Celularity (CELU) United States $0.091B 0.00
OKYO Pharma (OKYO) $0.089B 0.00
Pliant Therapeutics (PLRX) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Nautilus Biotechnology (NAUT) United States $0.089B 0.00
Quince Therapeutics (QNCX) United States $0.088B 0.00
Atara Biotherapeutics (ATRA) United States $0.087B 0.00
Elutia (ELUT) United States $0.086B 0.00
CervoMed (CRVO) United States $0.084B 0.00
Whitehawk Therapeutics (WHWK) United States $0.082B 0.00
EXoZymes (EXOZ) United States $0.078B 0.00
ABVC BioPharma (ABVC) United States $0.076B 0.00
Applied Therapeutics (APLT) United States $0.074B 0.00
Ovid Therapeutics (OVID) United States $0.073B 0.00
Sutro Biopharma (STRO) United States $0.073B 0.00
BioXcel Therapeutics (BTAI) United States $0.072B 0.00
BeyondSpring (BYSI) United States $0.071B 0.00
Artiva Biotherapeutics (ARTV) United States $0.070B 0.00
TELA Bio (TELA) United States $0.070B 0.00
Opus Genetics (IRD) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Repare Therapeutics (RPTX) Canada $0.068B 0.00
Fortress Biotech (FBIO) United States $0.068B 0.00
MiNK Therapeutics (INKT) United States $0.067B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.065B 0.00
KALA BIO (KALA) United States $0.065B 0.00
Genenta Science S.p.A (GNTA) Italy $0.064B 0.00
INmune Bio (INMB) United States $0.064B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
Immix Biopharma (IMMX) United States $0.063B 0.00
Aligos Therapeutics (ALGS) United States $0.063B 0.00
ALX Oncology Holdings (ALXO) United States $0.063B 0.00
Invivyd (IVVD) United States $0.062B 0.00
Adverum Biotechnologies (ADVM) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Earth Science Tech (ETST) United States $0.062B 0.00
InflaRx (IFRX) Germany $0.061B 0.00
Adicet Bio (ACET) United States $0.061B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Precision BioSciences (DTIL) United States $0.058B 0.00
ImageneBio (IMA) United States $0.057B 0.00
Clene (CLNN) United States $0.057B 0.00
PDS Biotechnology (PDSB) United States $0.055B 0.00
Quantum Biopharma (QNTM) Canada $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Lantern Pharma (LTRN) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.047B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Shattuck Labs (STTK) United States $0.046B 0.00
Grace Therapeutics (GRCE) Canada $0.045B 0.00
Rani Therapeutics Holdings (RANI) United States $0.045B 0.00
X4 Pharmaceuticals (XFOR) United States $0.045B 0.00
Pluri (PLUR) Israel $0.045B 0.00
Radiopharm Theranostics - (RADX) Australia $0.045B 0.00
Alterity Therapeutics - (ATHE) Australia $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
Generation Bio (GBIO) United States $0.043B 0.00
PepGen (PEPG) United States $0.043B 0.00
Senti Biosciences (SNTI) United States $0.043B 0.00
Renovaro (RENB) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.039B 0.00
CalciMedica (CALC) United States $0.039B 0.00
Mersana Therapeutics (MRSN) United States $0.039B 0.00
Exicure (XCUR) United States $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.034B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
Dyadic (DYAI) United States $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
Rein Therapeutics (RNTX) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.027B 0.00
Synaptogenix (TAOX) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Rallybio (RLYB) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
Passage Bio (PASG) United States $0.024B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.023B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
Cingulate (CING) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Tharimmune (THAR) United States $0.022B 0.00
Curis (CRIS) United States $0.021B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
Femasys (FEMY) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Moleculin Biotech (MBRX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Chemomab Therapeutics (CMMB) Israel $0.017B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.015B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Gelteq (GELS) Australia $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
IN8bio (INAB) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Portage Biotech (PRTG) $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Palisade Bio (PALI) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Aptevo Therapeutics (APVO) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00